Carrageenan is a family of sulfated linear galactans extracted from red seaweeds (Rhodophyta), primarily Chondrus crispus, Eucheuma, and Kappaphycus species. It is valued for its diverse gelling, thickening, and stabilizing functionalities.
Molecular Structure
Carrageenans comprise alternating β-(1→3)-D-galactopyranose (G units) and α-(1→4)-D-galactopyranose or 3,6-anhydro-α-D-galactopyranose (DA or D units), sulfated at varying positions to generate distinct structural families. The major types include κ-carrageenan (one sulfate group, G4S-DA), ι-carrageenan (two sulfate groups, G4S-DA2S), and λ-carrageenan (three sulfate groups, lacking the anhydro bridge).
These structural differences dictate functional behavior: κ-carrageenan forms firm and brittle potassium-ion–induced gels, ι-carrageenan produces elastic and freeze–thaw stable gels, and λ-carrageenan provides high viscosity without gel formation. Reported molecular weights typically range from 200 to 1000 kDa.
Extraction and Properties
Carrageenans are commonly extracted by alkaline hot-water treatment (80–100 °C, NaOH or KOH), which converts precursor forms (μ and ν carrageenans) into κ and ι types through the formation of 3,6-anhydro bridges. This process is followed by filtration, selective precipitation using potassium chloride (particularly for κ-carrageenan), and drying.
Key physicochemical properties include high water solubility (λ > ι > κ), cation-specific gelation (K⁺ for κ, Ca²⁺ for ι), shear-thinning rheological behavior, and stability across a broad pH range (4–10). Carrageenans exhibit thermal reversibility (more pronounced for ι than κ), synergistic interactions with locust bean gum, biodegradability, and polyelectrolyte characteristics driving coil-to-helix conformational transitions.
Biomedical and Pharmaceutical Applications
Carrageenans demonstrate a range of bioactivities, including antiviral effects against herpes simplex virus (HSV) and human papillomavirus (HPV) through polyanionic interference mechanisms, as well as anticoagulant and anti-inflammatory properties. κ- and ι-carrageenans are widely investigated for hydrogel formation in drug delivery systems, wound dressings with enhanced moisture retention, and tissue engineering scaffolds.
λ-carrageenan is frequently employed as a suspending and viscosity-enhancing agent in oral and parenteral pharmaceutical formulations. Its established biocompatibility also supports applications in nutraceuticals and functional foods, particularly for gut health–related formulations.
